NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors

NCT01324115 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Sponsor Decision

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: NG-nitro-L-arginine
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: computed tomography
PROCEDURE: dynamic contrast-enhanced magnetic resonance imaging

Sponsor

Cancer Research UK